Nonunion fractures, mesenchymal stem cells and bone tissue engineering
Authors:
- 2 May 2018
- journal article
- review article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 106 (9) , 2552-2562
Abstract
Depending on the duration of healing process, 5–10% of bone fractures may result in either nonunion or delayed union. Because nonunions remain a clinically important problem, there is interest in the utilization of tissue engineering strategies to augment bone fracture repair. Three basic biologic elements that are required for bone regeneration include cells, extracellular matrix scaffolds and biological adjuvants for growth, differentiation and angiogenesis. Mesenchymal stem cells (MSCs) are capable to differentiate into various types of the cells including chondrocytes, myoblasts, osteoblasts, and adipocytes. Due to their potential for multilineage differentiation, MSCs are considered important contributors in bone tissue engineering research. In this review we highlight the progress in the application of biomaterials, stem cells and tissue engineering in promoting nonunion bone fracture healing. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A:2551–2561, 2018.Keywords
Funding Information
- Mashhad University of Medical Sciences
This publication has 116 references indexed in Scilit:
- Predictors of nonunion and reoperation in patients with fractures of the tibia: an observational studyBMC Musculoskeletal Disorders, 2013
- Human Stromal (Mesenchymal) Stem Cells from Bone Marrow, Adipose Tissue and Skin Exhibit Differences in Molecular Phenotype and Differentiation PotentialStem Cell Reviews and Reports, 2012
- Biologic adjuvants for fracture healingArthritis Research & Therapy, 2012
- Degradation, Bioactivity, and Osteogenic Potential of Composites Made of PLGA and Two Different Sol–Gel Bioactive GlassesAnnals of Biomedical Engineering, 2011
- Concise Review: Insights from Normal Bone Remodeling and Stem Cell-Based Therapies for Bone RepairStem Cells, 2010
- Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2010
- High‐resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescenceJournal of Cellular and Molecular Medicine, 2007
- Molecular and cellular mechanisms of the anabolic effect of intermittent PTHBone, 2007
- P-15 small peptide bone graft substitute in the treatment of non-unions and delayed union. A pilot clinical trialInternational Orthopaedics, 2006
- Bone Morphogenetic ProteinsGrowth Factors, 2004